Caris Life Sciences (CAI) EBITDA Margin Growth (1y) (2025 - 2026)
Powered by 
Analysis
Caris Life Sciences (CAI) EBITDA Margin Growth (1y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.13 Bn | 46.03 Bn | 486.15 Mn | 1,012.00 |
| 2 | Labcorp Holdings | 26.44 Bn | 26.32 Bn | 1.11 Bn | 92.00 |
| 3 | Quest Diagnostics | 26.16 Bn | 25.84 Bn | 1.03 Bn | -78.00 |
| 4 | Guardant Health | 21.57 Bn | 20.51 Bn | 219.03 Mn | 731.00 |
| 5 | Tempus AI | 11.32 Bn | 10.51 Bn | 274.25 Mn | -21.00 |
| 6 | Caris Life Sciences | 7.08 Bn | 6.29 Bn | 182.38 Mn | 2,013.00 |
| 7 | Sotera Health | 5.39 Bn | 5.04 Bn | 177.96 Mn | 97.00 |
| 8 | BillionToOne | 4.65 Bn | 4.11 Bn | 77.11 Mn | 747.00 |
| 9 | iRhythm Holdings | 4.05 Bn | 3.46 Bn | 163.21 Mn | 889.00 |
| 10 | Adaptive Biotechnologies | 3.86 Bn | 3.53 Bn | 51.39 Mn | -1,173.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,013.00 |
| Mar 31, 2026 | 5,037.00 |
| Dec 31, 2025 | 5,870.00 |
| Sep 30, 2025 | 7,493.00 |
| Jun 30, 2025 | 5,706.00 |